Skip to main content
Clinical Trials/TCTR20200305002
TCTR20200305002
Active, not recruiting
未知

Responsiveness of Mini-Balance Evaluation System Test (Mini-BESTest) in Type II Diabetic Patients with Peripheral Neuropathy

/A0 sites48 target enrollmentMarch 5, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Type 2 Diabetic Patients with Peripheral Neuropathy
Sponsor
/A
Enrollment
48
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 5, 2020
End Date
October 8, 2020
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
/A

Eligibility Criteria

Inclusion Criteria

  • 1\) Patients aged between 40 †70 years
  • 2\) Diagnosis as type 2 diabetes with well\-controlled blood glucose based on follow up three times of medical assessments according to medical records
  • 3\) Screened with Michigan Neuropathy Screening Instrument (MNSI) and have a MNSI score ≥ 2\.5 out of 10 by the researcher (Herman et al. 2012\)
  • 4\) Diabetic duration of more than 5 years according to the medical record
  • 5\) Able to understand the instructions by mini\-mental state examination (MMSE ) (Roman de Mettelinge et al., 2013\)

Exclusion Criteria

  • 1\) Diagnosis as peripheral venous insufficiency, cardiac, renal or hepatic insufficiency, uncontrolled hypertension or myopathic by medical record
  • 2\) Diagnosis as central nervous system dysfunction (such as stroke, Parkinson’s disease, and cerebral ataxia) by medical record
  • 3\) Foot ulcers by physical examination
  • 4\) Fracture of the lower limbs within the 6 months before the study by physical examination
  • 5\) Partial or complete blindness by physical examination
  • 6\) Severe auditory problems by physical examination (Chatchawan, Eungpinichpong, Plandee, \& Yamauchi, 2015\) (Marques et al. 2017\)

Outcomes

Primary Outcomes

Not specified

Similar Trials